Coronavirus Vaccine

Coronavirus Vaccine

Dept. of Public Health

CTDPH STATEMENT ON PAUSE IN THE USE OF J&J VACCINE

The following is a statement from the Connecticut Department of Public Health on this morning’s announcement from the CDC and FDA that it is recommending that all states pause administering the J&J COVID-19 vaccine after six reports of an extremely rare adverse reaction to the vaccine:

Early this morning, the U.S. FDA and CDC issued a joint statement recommending a pause on the use of the Johnson & Johnson (J&J) COVID-19 vaccine following six reported US cases of a rare blood clotting event.

Although these events are rare, and none have occurred in Connecticut, the Connecticut Department of Public Health recommends that COVID vaccine providers pause on administration of J&J vaccine for the time being while the FDA and CDC complete their review. Of 6.8 million individuals who have received the J&J vaccine nationally, six individuals have developed a rare and severe type of blood clot called cerebral venous sinus thrombosis (CVST) within two weeks of receiving their vaccine.

All six cases occurred among women between age 18–48 years. Roughly 100,000 Connecticut residents have received the J&J vaccine with no reported serious adverse events.

The CDC, FDA and Connecticut DPH all take vaccine safety extremely seriously. Although the reported complications are extremely rare, we will await the results of the investigation before proceeding with
further use of the J&J vaccine.

DPH has informed vaccine providers that were planning to hold clinics using J&J today and in the coming days to delay these clinics or offer an alternative vaccine if they have alternative vaccines
available. DPH will work with providers to minimize the disruptions from this announcement in the near-term to the extent possible, but we anticipate that some cancellations will occur.
DPH has also encouraged providers to reach out to all individuals who were scheduled to come to a J&J clinic and let them know that their appointment will need to be rescheduled once the FDA and CDC have recommend resuming administration of the J&J vaccine.

The FEMA mobile unit, which is currently in New Britain, is working to further modify its schedule. It will be offering an mRNA vaccine instead of J&J vaccine when it resumes. The Griffin vaccine vans,
which currently administer J&J vaccine, have suspended their clinics for today. More information on the FEMA mobile unit and the Griffin vans will be forthcoming.

Although these side effects are extremely rare, the FDA and CDC recommend that people who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider.

***END***

Vaccine Eligibility

Individuals aged 16+ who lives, works, or studies in Connecticut are eligible to schedule appointments and receive a COVID-19 vaccine.

How to Schedule a COVID-19 Vaccine Appointment

Eligible individuals can schedule an appointment through the Vaccine Administration Management System (VAMS). The State of CT will enroll you into VAMS so that you can register and schedule an appointment through the portal. To be enrolled into VAMS, please fill out this form: STATE OF CT VAMS ENROLLMENT

Eligible individuals without an email address can schedule over the phone by calling the CT COVID Vaccine Appointment Assist Line at 877-918-2224. The Vaccine Appointment Assist Line is available seven days a week from 8:00 a.m. to 8:00 p.m. and will offer a call-back option when all contact specialists are busy serving other callers.

View all of your scheduling options: ALL SCHEDULING OPTIONS

Residents without Email Access (English/Spanish/Portuguese)

FAQ

The federal government has implemented a system to order, distribute, and track COVID-19 Vaccines. These vaccines are ordered through the CDC.

COVID-19 vaccines are a key method to stop the spread of COVID-19. COVID-19 affects individuals differently; sometimes cases are mild, but other times they are severe and can lead to death. Not only will it protect you, but it will also protect your loved ones from contracting the virus. The vaccine will help your body create antibodies against the virus, without contracting COVID-19.

No. The COVID-19 vaccine will help our bodies learn how to recognize and fight the virus that causes COVID-19. When our bodies are in the process of learning how to fight a virus and build immunity against it, we sometimes get symptoms such as a fever. This is not COVID-19, it is a normal sign that the body is building immunity against a virus.

Yes. The U.S. vaccine safety system ensures that safety is the top priority when creating vaccines. There have been thousands of clinical trial participants for the vaccine, and if the FDA determines that the vaccines are safe and effective, they are approved for emergency use.

Vaccine-safety monitoring systems continuously monitor for any adverse reactions that had not occurred during the clinical trials.

Additionally, smartphone technology allows for easy access to surveys where patients monitor how they are feeling and any side effects they may have after the vaccine, via the “V-Safe” app. The app also provides second dose alert reminders when necessary.

The doses of the COVID-19 vaccine that are paid for through the U.S. tax dollars will be at no cost. Providers of the vaccines may be able to charge administration fees, but may be able to get a reimbursement fee through the Health Resources and Service Administration’s Provider Relief Fund.

Because COVID-19 is still a novel virus, experts are still not sure how long an individual’s natural immunity to the virus will last. Therefore, people who have had COVID-19 may be advised to receive the vaccine. Speak to your physician and medical professionals for their recommendations.

In order to achieve the highest immunity against COVID-19 from the vaccine, two doses are needed for either Moderna or Pfizer.

The COVID-19 vaccine is currently being administered on an age-based eligibility system. As of 4/1/21, any individual living or working in CT is eligible for the COVID-19 vaccine.

Access VAMS - Eligible Residents Only

Common side effects of the COVID-19 vaccine include: pain and swelling where you got the shot, fever, chills, tiredness, and/or headache. They should go away within a few days. If redness or tenderness persists over 24 hours, or your side effects are worrying, call your doctor.

Reduce pain and discomfort by: applying a clean, cool, wet washcloth over the area and use/exercise your arm.

Reduce discomfort from fever: drink plenty of fluids and dress lightly.

Yes. Continue other safe practices, such as social distancing, wearing a mask, and abiding by proper sanitation measures. It is not known when this recommendation will end. Factors such as how many people get vaccinated and how the virus is spreading will affect this decision.

The VAERS system is used to collect any data on adverse events. It is important to understand the difference between a side effect and an adverse event.

A side effect is any health problem shown through studies, (such as a fever for the COVID-19 vaccine), or unrelated health problems that occur whether the vaccine was administered or not.

An adverse event is a true reaction to the vaccine, such as common known effects and/or allergic reactions.

Healthcare providers are required to report certain adverse events following the vaccine administration.

The smartphone V-safe app will help check how patients who received the COVID-19 are doing.

The CDC recommends the groups who should be offered the vaccine first. Each state has their own distribution plan, so the City of Danbury adheres to guidance created by the State of Connecticut.

The following link is a great resource for information in regards to COVID-19 Vaccine updates: COVID-19 Vaccine in Connecticut: Main Portal.

Click Here

Preferred Registration: It is recommended to register for the COVID-19 Vaccine through VAMS with an email address. You can assist a loved one by creating an email address at one the following sites: Gmail.com, yahoo.com, or aol.com. After the creation of the email, fill out the link below.

If you or someone you know is unable to create an email address, scheduling over the phone is available through the CT COVID Vaccine Appointment Line at (877)-918-2224.

VAMS - State of CT

Please bring a form of identification to the appointment.

If you have received a vaccination in the past 14 days, it is not recommended for you to get the COVID-19 Vaccine. The COVID-19 Vaccine should routinely be administered alone. Please schedule your COVID-19 Vaccine appointment for at least 14 days after your last vaccination.

You are eligible to receive your second dose of the Moderna Vaccine 28 days (+/-4) after your first dose. If you receive your first dose at the Danbury Health Department clinic, you will be asked to schedule your second appointment on site.

If you registered for your first vaccination online through VAMS, please schedule your succeeding appointment through VAMS as well. If you did not register online, please contact CT COVID Vaccine Appointment Line at (877)-918-2224.